These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3157510)

  • 21. Successful production of intrathyroidal human T cell hybridomas: evidence for intact helper T cell function in Graves' disease.
    Martin A; Schwartz AE; Friedman EW; Davies TF
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1104-8. PubMed ID: 2531154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
    Leedman PJ; Frauman AG; Colman PG; Michelangeli VP
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+CD45RA+ cells (suppressor-inducer T cells) in thyroid tissue from patients with Graves' disease.
    Kawakami A; Eguchi K; Matsunaga M; Tezuka H; Ueki Y; Shimomura C; Otsubo T; Nakao H; Migita K; Ishikawa N
    Acta Endocrinol (Copenh); 1991 Dec; 125(6):687-93. PubMed ID: 1838659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.
    Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Akasu F; Miller N; Jamieson C; Volpé R
    J Clin Endocrinol Metab; 1994 Feb; 78(2):367-74. PubMed ID: 8106624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease.
    Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Tezuka H; Nakao H; Kawakami A; Migita K; Ishikawa
    J Clin Endocrinol Metab; 1989 Nov; 69(5):939-45. PubMed ID: 2793996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
    Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous xenotransplantation of human Graves' thyroid tissue and autologous bone marrow cells in severe combined immunodeficient mice: successful reconstitution of human Graves' hyperthyroidism.
    Yoshikawa N; Nishikawa M; Mori S; Tokoro T; Yamamoto Y; Ikehara S; Kumazawa H; Yamashita T; Inada M
    Eur J Endocrinol; 1997 Feb; 136(2):213-22. PubMed ID: 9116918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of microsomal antigen and comparison with histologic localization of HLA-DR in Graves' thyroid tissue.
    Roman SH; Goldsmith NK; Leiderman IZ; Davies TF
    Autoimmunity; 1989; 2(3):253-63. PubMed ID: 2491609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
    Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
    Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal suppressive T cell function of Epstein-Barr virus-induced B cell activation in Graves' disease.
    Kahan A; Lefloch JP; Charreire J
    J Clin Endocrinol Metab; 1987 Sep; 65(3):555-60. PubMed ID: 3040797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.
    Goto Y; Itoh M; Ohta Y; Ogawa N; Goto Y; Ohashi H
    Thyroid; 1997 Aug; 7(4):567-73. PubMed ID: 9292944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of interleukins on EGF-stimulated growth promotion in human thyroid cells: differential modifications by IL-2 and IL-6 in Graves' and normal thyroid cells.
    Shimomura N; Itoh M; Okugawa T; Murata Y; Seo H
    Endocr Regul; 1994 Jun; 28(2):55-65. PubMed ID: 7949016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-TSH receptor antibodies in Graves' disease modulate the kinetic behaviour of autologous thyroid TSH receptors. Evidence of the IgG-induced cross-linkage of autologous TSH receptors.
    de Bruin TW; van der Heide D
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):330-40. PubMed ID: 6322495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased suppressor T-lymphocytes in autoimmune thyroid diseases detected by monoclonal antibodies.
    Sridama V; Pacini F; DeGroot LJ
    J Clin Endocrinol Metab; 1982 Feb; 54(2):316-9. PubMed ID: 6459338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunoregulatory influence of transforming growth factor beta in thyroid autoimmunity: TGF beta inhibits autoreactivity in Graves' disease.
    Widder J; Dorfinger K; Wilfing A; Trieb K; Pirich K; Loebenstein R; Niederle B; Gessl A; Spitzauer S; Grubeck-Loebenstein B
    J Autoimmun; 1991 Aug; 4(4):689-701. PubMed ID: 1777015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.
    Charreire J; Karsenty G; Bouchard P; Schaison G
    Clin Exp Immunol; 1984 Sep; 57(3):633-8. PubMed ID: 6147216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
    Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
    Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
    Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.